John Price, owner and MD of John Price PharmaSolutions LLC, is a life sciences regulatory and safety veteran and consultant. Formerly holding leading safety roles at Alexion, Johnson & Johnson, and Pfizer, and now an advisor to PV managed service provider Arriello, John has in-depth experience of the evolution of pharmacovigilance, extending back to the late 1980s/early 1990s. This includes a rich understanding of industry best practice, and the potential of intelligent automation in the drive towards high-quality, compliant AE reporting and improved patient safety.www.arriello.com